PremiumCompany AnnouncementsMarinus Pharmaceuticals Merges with Immedica Pharma AB Marinus Pharmaceuticals to be acquired by Immedica for 55c per share Marinus Unveils Management Retention and Severance Plans PremiumThe FlyMarinus Pharmaceuticals price target lowered to $1 from $3 at RBC Capital Marinus Pharmaceuticals price target lowered to $4 from $13 at Cantor Fitzgerald Marinus Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright PremiumThe FlyMarinus Pharmaceuticals downgraded to Market Perform at JMP Securities Marinus downgraded to Market Perform from Outperform at JMP Securities Marinus Pharmaceuticals downgraded to Hold from Buy at Truist